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Abstract
A three-step stacking capillary electrophoresis (CE) composed of ﬁeld-ampliﬁed sample injection, sweeping, and
analyte focusing by micellar collapse (FASI-sweeping-AFMC) was developed to determine dabigatran (D) and its major
active metabolite, dabigatran acyl-beta-d-glucuronide (DAG), in human plasma. After optimization and validation, this
novel approach was further applied to monitor 5 real samples, and the 25.2e186.8 ng mL¡1 D could be observed among
those. Based on these results, the novel CE stacking strategy was successfully applied for the analysis of D and DAG in
human plasma and could be served as a tool for clinical assays.
Keywords: Anticoagulant, Dabigatran, Dabigatran acyl-beta-d-glucuronide, FASI-sweeping-AFMC, Human plasma

1. Introduction

A

ntithrombotic therapy plays an important
role in the prevention and treatment of
thromboembolic disorders. However, currently
available agents such as warfarin and oral vitamin K
antagonists show numerous complex drug and food
interactions, resulting in unpredictable pharmacokinetic outcomes [1]. Additionally, some antithrombotic agents such as low molecular weight
heparin or fondaparinux are required with parenteral administration, resulting in a decrease of patients’ compliance. For the above reasons, oral

active thrombin inhibitors possessing few interactions with drugs or food would offer some
potential advantages over these agents. In 2010,
dabigatran etexilate (DE) (Pradaxa®), a novel direct
oral anticoagulant (DOAC), was approved for the
prevention of stroke and thrombosis in patients with
non-valvular atrial ﬁbrillation.
DE is a prodrug and further metabolized by
esterase to its active metabolite, dabigatran (D), in
vivo [2,3], and then this could be further metabolized
to form a glucuronide conjugate possessing pharmacological activity, dabigatran acyl-beta-d-glucuronide (DAG), which is the ﬁnal metabolite in
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humans [4]. Although D and DAG both have
pharmacological activity, D is only used as an anticoagulant for clinical use, and DAG is generally
regarded as a popular research subject in enzymology. Due to infrequent monitoring of the clotting tendency of blood in the treatment of D, it can
be offered as an alternative therapy for warfarin [5];
however, the U.S. Food and Drug Administration
(FDA) unexpectedly issued warnings in 2011 about
the bleeding risk of DE. Furthermore, related researches exhibited a relationship between plasma
concentration of D with the risk of bleeding (plasma
concentration of D > 200 ng mL1) and thrombosis
(plasma concentration of D < 50 ng mL1) [6,7]. For
these above-mentioned arguments, a suitable detective approach for the determination of D and
DAG levels in human plasma is necessary for clinical assays.
Up to now, coagulation tests have been widely
utilized to assess the safe dosage range of antithrombotic drugs in clinical settings; for example, the
prothrombin time (PT) and activated partial thromboplastin time (aPTT) have been evaluated for the
safety of D, although due to numerous interferences
from other coagulant drugs, endogenous changes in
coagulation factors or variations in responses to drugs
among the individuals, detection of PT or aPTT is
difﬁcult for assaying the safety of D in humans.
Because of these reasons, some approaches such as
HPLC-MS/MS, UPLC-UV, and UPLC-MS/MS have
been developed for detection of the real D level in vivo
to overcome these drawbacks. Among these approaches, UPLC-MS/MS has been frequently applied
for the determination of D levels in human plasma
due to its speciﬁcity and sensitivity while showing
satisfactory outcomes (about 0.2 ng mL1) [8,9]. Unfortunately, most laboratories in hospitals and clinics
can't afford the cost of the UPLC-MS/MS apparatus
and additionally, such instruments require an operator with specialized experience; consequently, a
speciﬁc approach with easy operation and inexpensive property is urgently needed for the determination of D and DAG levels in human plasma.
Capillary electrophoresis (CE) has become an
attractive analytical technique due to its high separation efﬁciency, short analysis time, less consumption of materials, and its facility to be widely applied
in different practical ﬁelds, including medicine,
pharmaceutics, chemistry, and biology [10e20].
However, the sensitivity of CE is comparatively low
due to the minor amount of sample injection and the
short optical length of capillary. To overcome this
problem, various on-line preconcentration approaches have been developed to increase the
sensitivity of CE, such as ﬁeld ampliﬁed sample
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stacking (FASS), ﬁeld ampliﬁed or enhanced sample
injection (FASI) [21,22], sweeping [23,24], large volume sample stacking (LVSS) [25,26], dynamic pH
junction [27], analyte focusing by micelle collapse
(AFMC) [28,29] and micelle to solvent stacking (MSS)
[30e32], etc. These on-line preconcentration approaches have more favorable traits such as ease of
manipulations without complicated modiﬁcations of
commercial CE instrumentation and the signiﬁcant
enhancement of sensitivity. Among these stacking
approaches, FASI utilizes the electrokinetic injection
of samples in a diluent with conductivity at least 10
times lower than the background solution (BGS). In
other words, it shows that the electric ﬁeld strength in
the sample zone is higher than that in the BGS zone,
and as a result, the electrophoretic velocity of ions in
the sample zone is faster. Ions migrate rapidly during
electrophoresis and slow down abruptly when they
encounter the BGS zone. The ions can be concentrated and stacked at the boundary between the BGS
and sample zone or water zone [33]. Sweeping relies
on the interaction of analytes with the micellar phase
that penetrates the sample zone and creates a
concentrated sample zone by physicochemical
properties. The AFMC mechanism is based on the
use of micellar pseudophase in the sample matrix,
and analytes covered with micelles can collapse into
a diluted zone of micelles to stack in the interface due
to low concentration of micelles resulting from the
difference of electric ﬁeld strength between the water
and BGS plug zone. The accumulated analytes are
subsequently separated by electrophoresis [34]. The
enhancement of sensitivity is limited when only a
single stacking approach is performed in a study. In
order to obtain further enhancement of sensitivity in
CE, numerous studies indicate the merging of more
than two stacking approaches into one CE separation. Currently, much of the literature has demonstrated the efﬁcacy of a three-step stacking approach
in CE is better than that of a single stacking approach
[33,35]. For this reason, the above-mentioned stacking approaches were combined in this study to
develop a novel three-step stacking CE approach.
Accordingly, a novel and convenient CE on-line
three-step stacking approach called FASI-sweepingAFMC, including FASI, sweeping, and AFMC was
designed and developed for the determination of D
and DAG levels in human plasma for clinical assays.
To our best knowledge, few studies have reported
the simultaneous determination of D and DAG
levels in human plasma by CE, so this sequential
three-step stacking (FESI, sweeping, and AFMC)
approach should be the ﬁrst article delineating the
determination of D and DAG levels in human
plasma in the ﬁeld of CE.
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2. Materials and methods
2.1. Chemicals and consumables
All of the analytes were analytical grade. D and
DAG were purchased from Cayman Chemical (Ann
Arbor, MI, USA). Clozapine as an internal standard
(IS), verapamil, amiodarone, propranolol, digoxin,
sodium dihydrogen phosphate (NaH2PO4), and sodium dodecyl sulfate (SDS) were purchased from
Sigma-Aldrich (St, Louis, MO, USA). Methanol
(MeOH), hydrochloric acid (HCl), and sodium hydroxide (NaOH) were obtained from E. Merck
(Darmstadt, Germany). Perchloric acid (HClO4) was
provided from Honeywell Fluka (Muskegon, MI,
USA). Sudan III was purchased from Katayama
Chemical (Osaka, Japan). The ultrapure water used
for the preparation of buffer and other aqueous
solutions was produced from Millipore Ultra-Pure
water system (Bedford, MA, USA).
2.2. CE system
Beckman PA800 MDQ (Fullerton, CA, USA) electrophoresis instrument equipped with a UV detector was used for the determination of D and DAG
levels in human plasma. The detective wavelength
was set at 214 nm. An uncoated fused silica capillary
(Polymicro Technologies, Phoenix, AZ, USA) of 50
mm I.D. and 50 cm total length (40 cm to the detector) was used. Before utilization of analysis, each
new capillary should be rinsed with MeOH, ultrapure water, 1 M HCl, ultrapure water, 1 M NaOH,
and ultrapure water, and each step was set at 30 psi
for 10 min. The temperature of capillary was maintained at 25  C, and the data obtained from tests
were collected and analyzed by using MDQ 32 Karat
software from Beckman.
2.3. Preparation of the plasma samples
All stock solutions of analytes including IS were
prepared with the acidic water of pH 3.0 at a concentration of 1 mg mL1. Patient plasma samples
were obtained from patients (P1eP5) with nonvalvular atrial ﬁbrillation taking DE during antithrombotic therapy. Additionally, the plasma obtained
from ﬁve healthy volunteers was used as the plasma
matrix in tests. Ethical approval for this study was
obtained from the Institutional Review Board (IRB)
of the Chung-Ho Memorial Hospital, Kaohsiung
Medical University, Kaohsiung, Taiwan (Number of
IRB: KMUHIRB-E(I)-20190422). All samples used in
the tests were stored at 20  C before use.

The 250 mL plasma sample was prepared in the
plasma matrix with an expected concentration of D,
DAG, and IS. Subsequently, 10 mL of 70% (V/V)
HClO4 was added into this plasma sample for precipitation of protein with vortex for 2 min. The
mixture was then centrifuged at 10000 rpm for 15
min. When centrifugation was completed, the supernatant was transferred into a 2 mL eppendorf
tube and then further extracted by solid phase
extraction (SPE). In the SPE procedure, the Oasis
HLB extraction cartridge (Waters, Wexford, Ireland)
was utilized for pretreatment of the supernatant,
with the procedure described as follows. Initially,
the SPE cartridge was conditioned with 2 mL
methanol and 2 mL ultrapure water respectively,
and the supernatant was then loaded into the cartridge, and following the loading, the SPE cartridge
was washed with 2 mL ultrapure water and 2 mL
10% (V/V) methanol respectively. The SPE cartridge
then was eluted with 1 mL methanol and the eluent
was collected, evaporated to dryness under vacuum,
and ﬁnally reconstituted with acidic water (pH 3.0).
The 100 mL reconstituted solution with 0.5 mg mL1
IS was analyzed by the developed CE system. The
real plasma samples from the patients taking DE
were also pretreated in the same procedure without
the addition of D and DAG.
2.4. FASI-sweeping-AFMC electrophoresis
Before separation, the capillary was rinsed with
the BGS (pH ¼ 2.5) composed of 100 mM NaH2PO4
at 30 psi for 10 min. Subsequently, the micellar solution (MS) (pH ¼ 2.5), composed of the BGS containing 50 mM SDS, was injected into the capillary
at 0.5 psi for 20 sec. Next, the BGS plug solution
(pH ¼ 2.5) of 100 mM NaH2PO4 was injected into the
capillary at 0.5 psi for 90 sec, and then ultrapure
water was injected into the capillary at 0.5 psi for 60
sec. After the above steps, the analytes were electrokinetically injected into the capillary at 10 kV for
300 sec and then separated at 20 kV. In this study,
the UV detector was set at the cathode side, detective wavelength was set at 214 nm, and the running
temperature during analysis was maintained at
25  C.
2.5. Method validation
In order to establish the calibration curves for
quantiﬁcation of D and DAG levels in human
plasma, ﬁve different concentrations of D (2.5, 10,
100, 250, 1000 ng mL1) and DAG (50, 100, 375, 500,
1000 ng mL1) were spiked into the plasma matrix
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and analyzed by this developed CE approach. All of
the plasma samples spiked with known concentrations of D and DAG were also pretreated according
to the procedures of section 2.3. The calibration
curves were established by comparison of the corrected peak area ratio of each analyte to IS (Y axis)
with the concentrations of each analyte in ng mL1
(X axis). In the analysis of the precision and accuracy, three different concentrations of D (5, 50, and
500 ng mL1) and DAG (75, 250, and 750 ng mL1)
were spiked into the plasma matrix and subsequently determined, with the results being evaluated by values of relative standard deviation (RSD)
and relative error (RE) from the three different
spiked concentrations in the analyses of both intraday and inter-day. The outcome of intra-day was
deﬁned as three repeated analyses (n ¼ 3) in a single
day, and the outcome of inter-day was deﬁned as
the same analysis over ﬁve different days (n ¼ 5). In
this study, the limit of detection (LOD) was determined in the plasma matrix using the diluted standard solution where the ratio of signal to noise was
equal to 3 (S/N ¼ 3).

sec, and the separated voltage and the buffer solution
were the same as those in the FASI-sweeping-AFMC.
However, in the consideration of the low sensitivity
for the typical injection CZE, the concentrations of
the analytes used in the typical injection CZE were 10
fold higher than those used in the FASI-sweepingAFMC, and results would be calibrated at the end of
the calculation. Based on the equation described
from these researches [31,37], the sensitivity
enhancement factors (SEFs) of the FASI-sweepingAFMC were calculated. The equation was as
following: SEFs ¼ [corrected peak area in the FASIsweeping-AFMC/corrected peak area in the typical
injection CZE]  [concentration in the typical injection CZE/concentration in the FASI-sweepingAFMC]. The corrected peak area described in the
equation was peak area of the analyte/migration time
of the analyte.

2.6. Stability and selectivity

In this study, the stacking CE techniques,
including ﬁeld-ampliﬁed sample injection, sweeping, and analyte-focusing by micellar collapse were
integrated into a three-step stacking CE procedure
(FASI-sweeping-AFMC) to determine the levels of
D and DAG in human plasma. The principle of this
developed CE approach is illustrated in Fig. 1.
Firstly, the fused silica capillary was ﬁlled with BGE,
micellar solution, BGS plug, and water sequentially
(Fig. 1A); secondly, the sample was injected electrokinetically into the capillary; and ﬁnally, when
the injected voltage was applied (anode was set at
the inlet), the anionic micelles and cationic analytes
would respectively migrate to the anode and cathode electrophoretically. During electrokinetic injection, it was noted that the stacking of FASI could
create a concentrated sample zone between the
water zone and the BGS plug due to the difference
of electric ﬁeld strength (Fig. 1B). Subsequently, as
the separation voltage (normal polarity, 20 kV) was
applied, the anionic micelles would penetrate the
sample zone and sweep the analytes toward the
anode to form the second stacking (Fig. 1C). At this
moment, the direction of effective electrophoretic
mobility for analytes was reversed from cathode to
anode due to charge change. However, when the
micelles carrying the analytes moved to the water
zone, the concentration of micelles would decrease
and become lower than the critical micelle concentration (CMC), resulting in the collapse of the micelles. Hence, the micelles would release the

The stability of our approach in CE during analysis was evaluated over 24 hours at room temperature. The RSD value of the peak area ratio (peak
area of analyte/peak area of IS) (n ¼ 3) was utilized
for evaluation of the stability, and it was considered
as stable when the RSD value was within ±5%. Besides, the selectivity of our approach in CE was
assessed by a comparison of the plasma matrix
containing 1 mg mL1 D, DAG, 0.5 mg mL1 IS, and 1
mg mL1 four antiarrhythmic drugs (verapamil,
amiodarone, propranolol, digoxin) chosen from the
viewpoint of participants under the treatment suggested by physicians [36] and the corresponding
controls.
Initially, the plasma matrix samples in this study
were pretreated and analyzed by the abovementioned procedure. Subsequently, the migration
time of any single peak was compared with that of
the corresponding controls to demonstrate the
selectivity of our approach in CE.
2.7. Sensitivity enhancing factors
In order to realize the sensitivity enhancement of
the FASI-sweeping-AFMC, a typical injection CZE as
a control group was performed to calculate the
sensitivity enhancement according to the literature
[31]. In the system of the typical injection CZE, the
analytes were injected into the capillary at 0.5 psi for 5

3. Results and discussion
3.1. Mechanism of the FASI-sweeping-AFMC
approach
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Fig. 1. Schematic diagrams of the FASI-sweeping-AFMC approach. (A) The starting situation, (BeD) injection, and the stacking process. (E) The
separation. The details of this mechanism have been explained in the results section.

analytes in the dilution zone to accomplish the third
stacking of the analytes. At this moment, the direction of effective electrophoretic mobility for analytes
was reversed again, and analytes would migrate
toward the cathode (Fig. 1D). Finally, the separation
of analytes was determined by their charge and
mass for separation, and the analytes were determined by UV detection at 214 nm wavelength
(Fig. 1E). Our approach provided three stacking
techniques, including FASI, sweeping, and AFMC in
the one-pot procedure, to achieve sensitivity
enhancement in CE analysis.
3.2. Optimization of the FASI-sweeping-AFMC
approach
In order to obtain the highest efﬁciency of stacking and separation in the FASI-sweeping-AFMC
approach, several parameters in CE analysis
including the pH value of the buffer system, the
concentration of BGS, the concentration of SDS, the
concentration of BGS plug, and sample injection
time were investigated as follows.
3.2.1. The pH value of the buffer system
In the CE system, the electrophoretic mobility is
dependent on the ionized level of analytes, and the
electroosmotic ﬂow (EOF) is controlled by the silanol

groups (SiOH) existing in the anionic form (SiO).
Both of them were greatly affected by the pH values
of the buffer system, so pH values play a key role in
the CE system. In this study, the buffer system was
composed of BGS, MS, and BGS plug solution, and
the pH values of the three solutions were investigated from 2.0 to 3.5 (Fig. 2). According to the results,
there was a noise peak presented at pH 2.0, and it did
not interfere with the separation of analytes. When
the pH value was higher than 2.5, the efﬁciency of
stacking and separation was similar; however, high
protonation of analytes (pH 2.0) would cause the
analytes to strongly interact with SDS micelles, and
the strong interaction would affect the release of
analytes from the SDS, resulting in poor efﬁciency of
stacking at pH 2.0 (Fig. 2A). Additionally, although in
the use of pH 3.5 (Fig. 2D), the interfering peaks were
fewer than others in the electropherograms, it consumes more time to separate. Separation time and
interfering peaks are both signiﬁcant factors for us to
ﬁnd the optimal condition. Although fewer interferences at pH 3.5, the separation time at pH 2.5
was shorter than that, and interferences at pH 2.5
would not affect the resolution of D and DAG. Due to
these reasons, pH 2.5 was selected as the optimal
condition of the pH value in the buffer system. Under
such pH value (pH 2.5), the mobility of the EOF is
3.27  105 cm2 V1 sec1.
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Fig. 2. Effect of pH ((A) pH 2.0; (B) pH 2.5; (C) pH 3.0; (D) pH 3.5) of buffer system on stacking and separation efﬁciency by the FASI-sweepingAFMC approach. The symbol x represents the signal of interference from plasma matrix. Sample concentrations: 1 mg mL1 D; 1 mg mL1 DAG; 0.5
mg mL1 IS. CE conditions: BGS, 100 mM NaH2PO4; MS, BGS contains 50 mM SDS; BGS plug, 100 mM NaH2PO4; Sample injection, 300 sec (10
kV); Separation voltage, 20 kV; Detection wavelength, 214 nm.

3.2.2. The BGS concentration
In this study, the BGS concentration was investigated from 75 to 150 mM (Fig. 3). When the BGS
concentration was 75 mM (Fig. 3A), the peak
heights of D and DAG were short. That was
because the ionic strength was not high enough for
focusing the D and DAG in the capillary. As the
BGS concentration increased, although the migration time of analytes was prolonged due to the low
electric ﬁeld strength at a higher concentration of
BGS, the higher concentrations of BGS could make
the D and DAG peaks taller and sharper. However,
when the BGS concentration reached 150 mM, the
peak shape of analytes became broad and crotched
(Fig. 3D). This was because higher BGS concentration has higher ionic strength, which generates a
higher current (up to 120 mA) to cause Joule heating, resulting in poor efﬁciency of stacking. Finally,
100 mM BGS solution was utilized in this CE
approach.
3.2.3. The SDS concentration
In the AFMC mechanism [38], proper SDS concentration would make micelles collapse easily at

the boundary between the water zone and the BGS
plug. The research indicated that the larger difference of electric ﬁeld strength or conductivity between both could obtain more improvement of
stacking efﬁciency. As the surfactant plays a key role
to improve sensitivity and resolution, the anionic
surfactant, SDS, was investigated from 0 to 100 mM
(Fig. 4). When the SDS concentration reached 100
mM, the SDS micelles were difﬁcult to collapse, and
the analytes could not be further accumulated in the
interface between the water zone and the BGS plug,
so the poor efﬁciency of stacking could be observed
at 100 mM of SDS (Fig. 4E). For the use of 25, 50, and
75 mM SDS (Fig. 4BeD), the efﬁciency of separation
and stacking were similar. An increase of SDS
concentration was beneﬁcial to sweeping, but it also
resulted in the insufﬁciency of collapsed micelles.
When 25 mM SDS was used, there were several
noise peaks closed to IS (Fig. 4B). Finally, 50 mM
SDS was selected as the optimal condition. Additionally, in the use of 0 mM SDS (Fig. 4A), poor efﬁciency of stacking was observed, so this indicated
that sweeping of the SDS micelles could improve
the stacking of analytes.
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Fig. 3. Effect of BGS concentration ((A) 75 mM; (B) 100 mM; (C) 125 mM; (D) 150 mM) on stacking and separation efﬁciency by the FASI-sweepingAFMC approach. Sample concentrations: 1 mg mL1 D; 1 mg mL1 DAG; 0.5 mg mL1 IS. CE conditions: BGS, NaH2PO4, pH 2.5; MS, BGS contains
50 mM SDS, pH 2.5; BGS plug, 100 mM NaH2PO4, pH 2.5; Sample injection, 300 sec (10 kV); Separation voltage, 20 kV; Detection wavelength, 214
nm.

3.2.4. The BGS plug concentration
In order to obtain better efﬁciency of stacking in
the FASI mechanism, the BGS plug was introduced
to produce the difference of electric ﬁeld strength
between the water zone and the BGS plug. Additionally, the BGS plug also affects the migration of
micelles sweeping toward the analytes. In this
study, the BGS plug concentration was investigated
from 50 to 200 mM (Fig. S1). As the concentration of
the BGS plug reached 150 and 200 mM (Fig. S1C-D),
the efﬁciency of stacking became worse, illustrating
that a high concentration of the BGS plug could
result in slow migration of micelles in the BGS plug,
which might cause the insufﬁciency of collapsed
micelles or poor sweeping. In the use of 50 mM BGS
plug, poor efﬁciency of stacking was also observed.
This was because that the difference of electric ﬁeld
strength between the water zone and the BGS plug
was not high enough to produce the stacking of
analytes in the interface during the electrokinetic
injection. Finally, this approach was performed by
using a 100 mM BGS plug.

3.2.5. The injection time of analytes
When analytes were electrokinetically injected
into the capillary (10 kV), the amount of analytes
introduced into the capillary was dependent on the
injection time. Therefore, the injection time was
investigated from 240 to 420 sec in this study
(Fig. S2). When the condition was set at 360 sec or
420 sec, the efﬁcacy of stacking decreased obviously,
and the peak shape became broad and crotched
(Fig. S2C-D). This showed that the length of the
sample zone was too long to stack effectively. For
this reason, injection time was set at 300 sec as the
optimal condition.
3.3. Method validations
In this study, the LOD (S/N ¼ 3) values of the D and
DAG in the FASI-sweeping-AFMC approach were
0.25 ng mL1 and 10 ng mL1 respectively. Additionally, the calibration curves of the D and DAG
were linear over the range of 2.5e1000 ng mL1 and
50e1000 ng mL1 respectively (data are shown in
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Fig. 4. Effect of SDS concentration ((A) 0 mM; (B) 25 mM; (C) 50 mM; (D) 75 mM; (E) 100 mM) on stacking and separation efﬁciency by the FASIsweeping-AFMC approach. Sample concentrations: 1 mg mL1 D; 1 mg mL1 DAG; 0.5 mg mL1 IS. CE conditions: BGS, 100 mM NaH2PO4, pH 2.5;
MS, BGS contains SDS, pH 2.5; BGS plug, 100 mM NaH2PO4, pH 2.5; Sample injection, 300 sec (10 kV); Separation voltage, 20 kV; Detection
wavelength, 214 nm.

Table 1). In the analysis of intra-day and inter-day,
the correlation coefﬁcients (r) of D and DAG were all
above 0.999, indicating a good linear response of this
FASI-sweeping-AFMC approach. In the analysis of
precision and accuracy, three different concentrations of D (5, 50, and 500 ng mL1) and DAG (75, 250,
and 750 ng mL1) were spiked into the plasma matrix
and then determined. The values of RSD and RE
could be obtained to evaluate the precision and accuracy respectively, and according to Table 2, the
good precision and accuracy of our approach were
obtained. All values of the RSD and RE obtained from
the analysis of intra-day and inter-day were less than
5%, and it showed good applicability of our approach
for the analysis of biological samples.
3.4. Stability and selectivity
In order to evaluate the stability of our approach
during analysis, the study of stability was executed for
24 hours at room temperature. In this study, the stability was presented as the RSD value of the peak area
ratios for 24 hours (data shown in Fig. S3). During the
24 hour analysis, the RSD values of the peak area

ratios of D and DAG were 3.7% and 3.4% respectively.
This data validated the excellent stability of our
approach and ensured stable outcomes for the
quantiﬁcation of D and DAG levels in plasma over 24
hours. Additionally, the selectivity of our approach
was conﬁrmed by a comparison of the plasma matrix
containing 1 mg mL1 D, DAG, 0.5 mg mL1 IS, and 1
mg mL1 four antiarrhythmic drugs (verapamil,
amiodarone, propranolol, digoxin) chosen from the
viewpoint of participants under treatment suggested
by physicians [32] and the corresponding controls.
The data (Fig. S3B) showed that these analytes could
be well-resolved under interferences resulting from
the plasma matrix and interaction of these antiarrhythmic drugs. In summary, the results of this study
indicated the high selectivity of this approach towards
the identiﬁcation of the target analytes, and four other
antiarrhythmic drugs were conﬁrmed.
3.5. The comparison with other stacking CE
methods
In this research, the various stacking CE strategies
and the typical injection CZE method were also

Table 1. Regression analysis for the determination of D and DAG levels.
Analytes
Intra-day (n ¼ 3)
Dabigatran
Dabigatran acyl-beta-d- glucuronide
Inter-day (n ¼ 5)
Dabigatran
Dabigatran acyl-beta-d- glucuronide

Linear range
(ng mL1)

Regression equation

Correlation
coefﬁcient (r)

2.5e1000
50.0e1000

Y ¼ (0.0092 ± 0.0002) X þ (0.2219 ± 0.0513)
Y ¼ (0.0035 ± 0.0005) X þ (0.0175 ± 0.0548)

0.9991
0.9995

2.5e1000
50.0e1000

Y ¼ (0.0090 ± 0.0002)X þ (0.1295 ± 0.0616)
Y ¼ (0.0034 ± 0.0002)X e (0.0418 ± 0.0534)

0.9995
0.9993
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Table 2. Analysis of the precision and accuracy for the determination of D and DAG levels.
Analytes
Intra-day (n ¼ 3)
Dabigatran

Dabigatran acyl-beta-d- glucuronide

Inter-day (n ¼ 5)
Dabigatran

Dabigatran acyl-beta-d- glucuronide

Concentration
known (ng mL1)

Concentration
found (ng mL1)

RSD (%)

RE (%)

5
50
500
75
250
750

5.14 ± 0.11
50.68 ± 2.15
505.17 ± 6.31
78.05 ± 1.02
251.28 ± 0.79
761.03 ± 3.15

2.08
4.24
1.25
1.30
0.31
0.41

2.79
1.37
1.03
4.07
0.51
1.47

5
50
500
75
250
750

5.05 ± 0.11
50.12 ± 0.82
502.00 ± 6.35
76.32 ± 1.97
252.89 ± 3.00
753.74 ± 2.59

2.22
1.63
1.26
2.59
1.19
0.34

1.04
0.25
1.01
1.76
1.16
0.50

performed to compare with the FASI-sweepingAFMC by using the standard analytes. The data was
as shown in Fig. S4. In the FASI-sweeping-AFMC
(Fig. S4A), the D and DAG were well separated and
stacked. When the separation was performed in the
mode of the FASI-sweeping (Fig. S4B), the D and
DAG were coupled. In the FASI-sweeping mode, the
separation was set in the reverse polarity (The anode
is set in the outlet), and the SDS (50 mM) micelles set
in the inlet and outlet reservoir were continuously
introduced into the capillary to sweep the analytes.
The data indicated the continuous anionic SDS micelles under such conditions could sweep the analytes to the detector (anode), but could not resolve D
and DAG. However, in the mode of the FASIsweeping-AFMC, the separation was set in the
normal polarity (The detector and cathode are in the
outlet) and the SDS (50 mM) was present in a short
plug (0.5 psi, 20 sec, about 1.3 cm of 50.0 cm total
capillary length). Theoretically, the analytes would
migrate to the inlet of the capillary due to the
sweeping of the micelles, but the D and DAG could
also be detected. Additionally, the mobility of the
SDS micelles (3.40  104 cm2 V1sec1) was about
ten-fold higher than that of EOF (3.27  105 cm2
V1sec1) under pH 2.5, and the analytes could not be
pushed to the detector by EOF in the presence of the
SDS micelles. Therefore, that meant the anionic micelles would be collapsed during separation, and the
analytes were released to the free solution and
moved to the cathode by EOF and their cationic
charge. Second, in this study, the SDS (50 mM) micelles only occupied 2.6% of the total capillary (0.5
psi, 20 sec, about 1.3 cm of 50.0 cm total capillary
length), and the SDS concentration would be
decreased gradually due to distribution in the BGS
plug and the water zone as micellar dilution zone
(MDZ) during analysis. Finally, it would be low than

CMC to be collapsed and release the cationic analytes. If the micelles were not collapsed, the analytes
would migrate to the inlet by the sweeping of the
anionic micelles, and the signals of analytes were not
detected by the detector in the cathode. In the FASI
mode (Fig. S4C), the stacking efﬁciency was very
poor for D and DAG, although they were well separated. In the comparison of the FASI-sweepingAFMC and the FASI, it could be found the migration
time became longer in the FASI-sweeping-AFMC
due to the transient sweeping of the analytes to inlet
by the short plug of SDS, and that also demonstrated
the sweeping of the anionic SDS micelles were much
helpful for sacking D and DAG.
3.6. Sensitivity enhancing factors
In order to know the sensitivity enhancement of the
FASI-sweeping-AFMC, a typical injection CZE was
also performed (Fig. S4D), and the sensitivity
enhancement factors (SEFs) of the FASI-sweepingAFMC were calculated. In the comparison of the
typical injection CZE as the controlled group, the
SEFs of the FASI-sweeping-AFMC were obtained.
Based on the results (Table S1), the sensitivity was
increased signiﬁcantly in the FASI-sweeping-AFMC,
and the SEFs of the FASI-sweeping-AFMC for D and
DAG were 1572 and 634, respectively. The data has
demonstrated that there was a sensitivity improvement by using the FASI-sweeping-AFMC for the
determination of D and DAG when compared to the
typical injection CZE.
3.7. Evaluation of SDS micelles collapse by using
Sudan III
In this approach, the sweeping and the collapse of
micelles played important roles for stacking the

Table 3. Characteristics and detected results of ﬁve patients in this study.
Patient
No.

Sex

Age
(yr)

Weight
(kg)

Dosage
(mg/kg/day)

eGFR
(mL/min/1.73 m2)

D levela
(ng mL1) (n ¼ 3)

DAG level
(ng mL1) (n ¼ 3)

P1
P2
P3
P4
P5

F
M
M
F
M

85
77
78
59
69

60
61.3
79
78.2
59.4

3.7
3.6
2.8
2.8
5.1

61.7
66.3
49.0
90.0
84.7

186.8 ± 17.4
170.4 ± 14.2
110.6 ± 9.5
184.7 ± 8.9
25.2 ± 1.6

NDb
57.6 ± 2.1
<50.0c
<50.0c
74.5 ± 3.4

a
b
c

Normal therapy range: 50e200 ng mL1.
ND, not detected. The value is lower than LOD (<10 ng mL1).
The value was higher than LOD (>10 ng mL1), but lower than LOQ (<50 ng mL1).

analytes. In order to further conﬁrm the collapse of
SDS micelles in the use of such SDS concentrations,
the Sudan III was utilized as a marker to evaluate the
collapses of SDS micelles. Sudan III is utilized as a
micellar marker, because it would be totally included
into the micelles. In this study, the separation was set
in the normal polarity (20 kV), and the detector was
set in the cathode (the cathode is in the outlet).
Therefore, the Sudan III was used as the analyte to
perform this investigation under the same experimental setting (section 2.4) and conditions (BGS, 100
mM NaH2PO4, pH 2.5; MS, BGS contains SDS, pH 2.5;
BGS plug, 100 mM NaH2PO4, pH 2.5; Sample injection, 300 sec, 10 kV; Separation voltage, 20 kV;
Detection wavelength, 214 nm.) as those for the
determination of D and DAG in this study, and the
data was as shown in Fig. S5. The various SDS concentrations from 0 mM to 100 mM were tested
(Fig. S5B-F). The concentration of Sudan III utilized in
the experiment was 300 mg mL1 (about 0.85 mM)
which was much less than the SDS concentrations
and could be totally included by the SDS micelles.
When no SDS was used, the peak of the Sudan III was
broad (Fig. S5B), and it also displayed the Sudan III
carried the positive charge. As soon as increasing the
SDS concentrations from 25 to 100 mM, the peak of
the Sudan III became sharper. That is meaning the
sweeping of the SDS micelles would be beneﬁcial for
stacking. However, in such normal polarity (20 kV),
the SDS micelles possessing the large negative charge
would move toward the inlet (anode). In the consideration of the EOF, the mobility of the SDS micelles
(3.40  104 cm2 V1sec1) was about ten-fold higher
than that of EOF (3.27  105 cm2 V1sec1) under pH
2.5, and the analytes could not be pushed to the detector by EOF in the presence of the SDS micelles.
Nevertheless, the Sudan III could be detected in such
conditions, meaning the micelles must be collapsed.
If the SDS micelles were not collapsed, the Sudan III
would be totally included by the SDS micelles and
migrate to the inlet (the anode is in the inlet, and the
detector (cathode) is in the outlet). Therefore, the data
demonstrated the Sudan III was ﬁrstly swept by the
SDS micelles to make the sharp peak and then

released by the collapse of the SDS micelles, and
ﬁnally moved to the detector (cathode) by its electrophoretic mobility and EOF. Additionally, in the use
of the 100 mM SDS, the peak of the Sudan III became
small. That could be supported the SDS micelles were
more difﬁcultly collapsed under such high SDS concentration, and a portion of the Sudan III was lost by
the including of the micelles without collapsing. In
the use of 50 mM SDS (Fig. S5D) which was the
optimal condition in this research, the peak area was
almost the same as that in the use of no SDS, meaning
the SDS micelles were almost completely collapsed.
The data could demonstrate the sweeping and the
collapse of the SDS micelles were both helpful for
stacking analytes in this research.
3.8. Application
In this study, 5 patients with nonvalvular atrial
ﬁbrillation participated in this experiment and provided their plasma after taking DE. All blood sampling time was within 3 hours after taking DE. After
the pretreatment of the sample and the analysis in
CE, different D and DAG levels could be observed
in plasma samples of ﬁve different patients (as
shown in Table 3). These real plasma samples from
the patients were also pretreated in the same procedure (section 2.3) without spiking D and DAG.
Although 250 mL plasma was used and then 100 mL
solution was reconstituted, the calibration curves
were also established according to the same procedure. According to this uniformity of pretreated
procedures, the concentrations of D and DAG in the
real samples could be directed quantiﬁed through
the calibration curves. The electropherograms of the
plasma samples obtained from two patients (P2 and
P5) are as shown in Fig. 5, and the data indicated
that this developed CE approach could be utilized
for the detection of D and DAG levels in human
plasma for clinical evaluation. In the electropherograms, there was an interference next to the peak of
D. It's worth noting that the interference next to D is
also increased after spiking. In the comparison of
the electropherogram by using standard solutions
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Fig. 5. Electropherograms of D and DAG levels in the plasma samples obtained from two (P2 and P5) patients. (A) P2, black line: real patient's
plasma sample; red dotted line: patient's plasma sample spiked with standard solutions (B) P5, black line: real patient's plasma sample; red dotted
line: patient's plasma sample spiked with standard solutions.

as analytes (Fig. S4A), that could be found the
interference peak resulted from plasma. The signal
increase after spiking was supported from the
electrokinetic injection in this mode, and the unknown interaction between this endogenous interference and target analytes. However, the
interference would not affect the separation and
quantiﬁcation of D.
Among these data (Table 3), the D level of one
patient (P5) was lower than the normal therapeutic
range (50e200 ng mL1) in human plasma after
intake of high DE dosage (150 mg BID). After
tracking this patient's records, it was found that his
medication compliance was very poor. Additionally,
his DAG level was the highest among the 5 plasma
samples, indicating that the sampling time of this
patient was inaccurate, resulting in the low level of
D and the high level of DAG. Although the plasma
DAG levels in the P3 and P4 were less than the
LOQ, those in P2 and P5 could be successfully
quantiﬁed according to the calibration curves. Until
now, only few studies have mentioned the DAG, but
they did not deﬁne the appropriate plasma level in
clinical. Based on the results of this approach, physicians could offer individual suggestions of treatment to patients. Furthermore, the different DAG

levels in this study, which might result from the
variety of glucuronosyltransferase activity in the
population, could offer fresh insight for clinicians
and investigators specializing in pharmacokinetics
and gene polymorphism.
Until now, numerous approaches have been
established for the determination of D levels in
human plasma or serum. In comparison with previous researches (Table 4), although analytical time
and consumption of plasma samples in this study
were little more than some of those, this approach
still possessed the advantages, such as the similar
detection range of D in plasma without the use of
mass spectrophotometry, simple instrumental
conﬁguration, less consumption of materials and
organic solvent, and inexpensive cost of the instruments. All results demonstrated that the FASIsweeping-AFMC approach in CE was a better tool
for the determination of D and DAG levels in
human plasma and reference in precision medicine.

4. Conclusions
In this study, a novel and convenient CE on-line
three-step stacking approach called the FASIsweeping-AFMC, including FASI, sweeping, and
AFMC approaches was successfully established for

Table 4. The comparison of the approaches for determination of D levels in human plasma.
Method

Linear range
(ng mL1)

LOD
(ng mL1)

Analyte

Ref.

UHPLC-MS/MS
SPE-UHPLC-MS/MS
UHPLC-MS/MS
UHPLC-UV
UHPLC-MRM-MS
FASI-sweeping-AFMCa

2.4e384
0.5e900
2.0e500
20.0e1000
0.8e800
2.5e1000
50.0e1000

0.24
0.18
0.63
4.00
0.21
0.25
10.00

D
D
D
D
D
D
DAG

[8]
[39]
[40]
[41]
[9]
This research

a

A three-step capillary electrophoresis of ﬁeld-ampliﬁed sample injection, sweeping, and analyte focusing by micelle collapse.

the determination of D and DAG levels in human
plasma. This is the ﬁrst time that a sequential threestep stacking approach in CE used for the determination of D and DAG levels in human plasma has
been developed and applied. After the validation of
this approach, these data demonstrated good linearity, precision, accuracy, stability, and selectivity of
this approach for analysis of D and DAG in plasma
matrix samples. This approach was further applied
for the determination of D and DAG levels in the
plasma samples of ﬁve patients. All results showed
that this approach is feasible for the clinical determination of D and DAG levels in human plasma.
Most importantly, it possesses superior properties
compared to previous UPLC-MS/MS works such as
the similar detection range of D and DAG, good
sensitivity, simple experimental design, less consumption of materials, and inexpensiveness. In
contrast with similar research [33,35], the experimental process could be simpliﬁed due to the
operation without the switch of electrodes during
the analysis. Furthermore, valuable application in
clinical use has been demonstrated according to the
results of this research. For the above-mentioned
arguments and results, this developed approach

99

was feasible for the determination of D and DAG
levels in human plasma and could serve as a tool for
clinical assays.
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Appendix A. Supporting information

Fig. S1. Effect of BGS plug concentration ((A) 50 mM; (B) 100 mM; (C) 150 mM; (D) 200 mM) on stacking and separation efﬁciency by the FASIsweeping-AFMC approach. Sample concentrations: 1 mg mL1 D; 1 mg mL1 DAG; 0.5 mg mL1 IS. CE conditions: BGS, 100 mM NaH2PO4, pH 2.5;
MS, BGS contains 50 mM SDS, pH 2.5; BGS plug, NaH2PO4, pH 2.5; Sample injection, 300 sec (10 kV); Separation voltage, 20 kV; Detection
wavelength, 214 nm.
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Fig. S2. Effect of injection time ((A) 240 sec; (B) 300 sec; (C) 360 sec; (D) 420 sec) of analytes on stacking and separation efﬁciency by the FASIsweeping-AFMC approach. Sample concentrations: 1 mg mL1 D; 1 mg mL1 DAG; 0.5 mg mL1 IS. CE conditions: BGS, 100 mM NaH2PO4, pH 2.5;
MS, BGS contains 50 mM SDS, pH 2.5; BGS plug, 100 mM NaH2PO4, pH 2.5; Sample injection, 10 kV; Separation voltage, 20 kV; Detection
wavelength, 214 nm.

Fig. S3. Summary of stability and selectivity of the FASI-sweeping-AFMC approach in human plasma. (A) Results of RSD for the stability of the
developed approach over 24 hours at room temperature. (B) Electropherogram of the plasma sample spiked with 1 mg mL1 D, DAG, 0.5 mg mL1 IS,
and 1 mg mL1 four antiarrhythmic drugs (V: Verapamil, A: Amiodarone, P: Propranolol, Di: Digoxin).
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Fig. S4. Electropherograms of the (A) FASI-sweeping-AFMC; (B) FASI-sweeping; (C) FASI and (D) typical injection CZE for the analysis of D and
DAG. (A) FASI-sweeping-AFMC conditions could be referred in section 2.4; (B) FASI-sweeping conditions were as following: BGS, 100 mM
NaH2PO4 (pH 2.5); water plug, 0.5 psi for 5 sec; Sample injection, 10 kV for 300 sec; sweeping buffer, 50 mM SDS in BGS; Separation, 20 kV; (C)
FASI conditions were as following: BGS, 100 mM NaH2PO4 (pH 2.5); water plug, 0.5 psi for 5 sec; Sample injection, 10 kV for 300 sec; Separation, 20
kV; (D) typical injection CZE conditions were as following: BGS, 100 mM NaH2PO4 (pH 2.5); Sample injection, 0.5 psi for 5 sec; Separation, 20 kV.
All of the detection was accomplished at 214 nm. All of the analytes were the standard solution.

Fig. S5. The electropherograms of Sudan III in the FASI-sweeping-AFMC mode by using the (A) 50 mM SDS without Sudan III (blank); (B) 0 mM
SDS; (C) 25 mM SDS; (D) 50 mM SDS; (E) 75 mM SDS and (F) 100 mM SDS. Sample: Sudan III, 300 mg mL1 (about 0.85 mM << SDS
concentration used in this study). Other conditions are the same as those shown in Fig. 4.
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Table S1. The sensitivity enhancement factors (SEFs) of the FASIsweeping-AFMC compared to the typical injection CZE
Method
(n ¼ 3)
1

Concentration (mg mL )
Migration time (min)
Corrected peak area
SEFsc

Typical injection CZEb

D

DAG

D

DAG

[13]

1
6.7
98725
1572

1
9.5
33450
634

10
6.5
628

10
9.4
528

[14]
[15]

1

FASI-sweeping-AFMC: 1 mg mL standard solution of each
analyte in acidic water of pH 3.0; injection at 10 kV for 300 sec.
b
Typical injection CZE: 10.0 mg mL1 standard solution of each
analyte in acidic water of pH 3.0; injection at 0.5 psi for 5 sec.
c
SEFs ¼ [corrected peak area in the FASI-sweeping-AFMC/
corrected peak area in the typical injection CZE]  [concentration
in the typical injection CZE/concentration in the FASI-sweepingAFMC].
a

[12]

FASI-sweepingAFMCa
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